文献速递腹部技术与安全USMR

以MRI质子密度脂肪分数为参考评估衰减参数对肝脂肪变分期的诊断效能:三种超声设备的 prospective 比较

Diagnostic Performance of Attenuation to Stage Liver Steatosis with MRI Proton Density Fat Fraction as Reference: A Prospective Comparison of Three US Machines.
PubMed 文献 · Radiology · 2022-07-12

这项前瞻性单中心研究纳入534例慢性肝病患者,同日行MRI质子密度脂肪分数(PDFF)定量和三种厂商超声衰减参数测量,比较其分期肝脂肪变的诊断效能;结果显示不同厂商衰减参数诊断效能存在差异,部分厂商表现优异且截断值相近,且衰减与肝硬度无关。

要点

  • 三种超声设备衰减参数与MRI PDFF的相关系数分别为0.71、0.73和0.54,厂商3明显较低。
  • 诊断脂肪变≥S1和≥S2的AUC:厂商1为0.89和0.93,厂商2为0.88和0.92,厂商3为0.79和0.79。
  • 验证样本中诊断≥S1的截断值:厂商1为0.65(敏感度77%、特异度78%),厂商2为0.66(敏感度84%、特异度85%)。

核心结论

  • 以MRI PDFF定量为参考标准,不同厂商超声设备的衰减参数对肝脂肪变分期的诊断效能存在差异,部分厂商表现出优异的诊断效能且截断值相近。

研究设计与样本

  • 前瞻性单中心研究,2020年7月至2021年6月连续纳入534例慢性肝病患者(平均年龄60岁±13[SD],320例男性),同日行MRI PDFF定量(参考标准)和三种厂商中两种超声设备的衰减参数测量。

关键影像表现/征象

  • 所有厂商的测量失败率均低于1%。
  • 衰减参数与MRI PDFF的相关系数:厂商1为0.71,厂商2为0.73,厂商3为0.54。
  • 所有厂商的衰减参数与肝硬度均无关(相关系数<0.05)。

诊断标准与关键数值

  • MRI PDFF分期标准:≥5.5%为≥S1级,≥15.5%为≥S2级。
  • 测试样本中诊断≥S1和≥S2的AUC:厂商1衰减为0.89和0.93,厂商2为0.88和0.92,厂商3为0.79和0.79。
  • 验证样本中诊断≥S1的截断值:厂商1为0.65(敏感度77%、特异度78%),厂商2为0.66(敏感度84%、特异度85%)。
  • 厂商2衰减诊断≥S1和≥S2的AUC均大于厂商3(P=.001和P=.003),诊断≥S2的AUC大于厂商1(P=.04)。

临床应用与阅片要点

  • 使用超声衰减参数评估肝脂肪变时,应了解不同厂商设备诊断效能存在差异,部分厂商截断值相近。
  • 衰减参数与肝硬度无关,可能不受纤维化程度影响。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background US tools to quantify liver fat content have recently been made clinically available by different vendors, but comparative data on their accuracy are lacking. Purpose To compare the diagnostic performances of the attenuation parameters of US machines from three different manufacturers (vendors 1, 2, and 3) in participants who underwent liver fat quantification with the MRI-derived proton density fat fraction (PDFF). Materials and Methods From July 2020 to June 2021, consecutive participants with chronic liver disease were enrolled in this prospective single-center study and underwent MRI PDFF quantification (reference standard) and US on the same day. US was performed with two different machines from among three vendors assessed. Areas under the receiver operating characteristic curve (AUCs) for the staging of liver steatosis (MRI PDFF: ≥5.5% for grade ≥S1 and ≥15.5% for grade ≥S2) were calculated in test and validation samples and then compared between vendors in the study sample. Results A total of 534 participants (mean age, 60 years ± 13 [SD]; 320 men) were evaluated. Failure of measurements occurred in less than 1% of participants for all vendors. Correlation coefficients with the MRI PDFF were 0.71, 0.73, and 0.54 for the attenuation coefficients of vendors 1, 2, and 3, respectively. In the test sample, AUCs for diagnosis of steatosis grade S1 and higher and grade S2 and higher were 0.89 and 0.93 for vendor 1 attenuation, 0.88 and 0.92 for vendor 2 attenuation, and 0.79 and 0.79 for vendor 3 attenuation, respectively. In the validation sample, a threshold value of 0.65 for vendor 1 and 0.66 for vendor 2 yielded sensitivity of 77% and 84% and specificity of 78% and 85%, respectively, for diagnosis of grade S1 and higher. Vendor 2 attenuation had greater AUCs than vendor 3 attenuation (P = .001 and P = .003) for diagnosis of grade S1 and higher and grade S2 and higher, respectively, and vender 2 had greater AUCs for attenuation than vendor 1 for diagnosis of grade S2 and higher (P = .04). For all vendors, attenuation was not associated with liver stiffness (correlation coefficients <0.05). Conclusion To stage liver steatosis, attenuation coefficient accuracy varied among US devices across vendors when using MRI proton density fat fraction quantification as the reference standard, with some demonstrating excellent diagnostic performance and similar cutoff values. © RSNA, 2022 Online supplemental material is available for this article. See also the editorial by Dubinsky in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Cassinotto, Jacq, Anselme, et al. Diagnostic Performance of Attenuation to Stage Liver Steatosis with MRI Proton Density Fat Fraction as Reference: A Prospective Comparison of Three US Machines. Radiology. 2022. PMID: 35819322. doi:10.1148/radiol.212846

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。